The public record for this applicant is narrow. FDA records linked by MedtechLedger show one 510(k) entry, K260230, with a Substantially Equivalent decision dated October 22, 2026, received January 26, 2026, and reviewed under product code BWK with device class listed as U. The submission is a Traditional 510(k) with no third-party review, and the review advisory committee is recorded as NE with an unknown advisory committee description. The applicant address in the filing is #18 Huatuo Rd., Sstt, 215163 Suzhou New District, Suzhou, China, with Xuejiao Song listed as applicant contact. The October 22, 2026 FDA letter addresses correspondence to the applicant care of Boyle Wang, General Manager, ABMED MEDICAL TECHNOLOGY PTY, Ltd., St Leonards, Australia. [1][2][3][4]
Documented device and technology
K260230 covers a Needle Stimulator marketed under four model designations: SDZ-IIB, SDZ-IIC, SDZ-III, and SDZ-V. FDA's clearance letter describes the Needle Stimulator as an electro-acupuncture stimulator device, indicated for use in the practice of acupuncture by qualified practitioners of acupuncture as determined by the states. The product code is BWK, whose classification name is Stimulator, Electro-Acupuncture; the device class is recorded as U and the review panel as NE. [1][2][3][6]
A published instruction manual for the SDZ-II identifies the manufacturer as Suzhou Medical Appliance Factory at No. 18 Huatuo Rd., SSTT, 215163 Suzhou New District, China, and describes the product as an electronic instrument for acupuncture treatment under the Hwato brand, with a European authorized representative listed as Shanghai International Holding Corp. GmbH in Hamburg. That manual documents the SDZ-II model, not the four model designations named in K260230. [5]
Filing record and review timing
The K260230 record shows a date received of January 26, 2026 and a decision date of October 22, 2026, with decision code SESE and decision description Substantially Equivalent. The submission is marked Traditional, third-party flag N, and statement or summary Summary. The FDA letter carries a September 22, 2026 date and receipt date for the reviewed material. [1][2][4]
An independent research platform, FDAcleared.org, lists two 510(k) clearances for this applicant, a 191.5-day average review velocity that it describes as 35 percent longer than its industry benchmark, and a first clearance date of 2007-03-22 alongside a latest date of 2026-10-22. Those figures are that publisher's aggregation and are not confirmed by the FDA records linked here, which show only K260230. [7]
Applicant identity and related parties
The FDA legal applicant on K260230 is Suzhou Medical Appliance Factory, with the Suzhou New District address and Xuejiao Song as contact. The clearance letter routes correspondence through Boyle Wang, General Manager, at ABMED MEDICAL TECHNOLOGY PTY, Ltd. in St Leonards, New South Wales, Australia. No parent, subsidiary, or brand ownership relationship among these parties is stated in the records. [1][2][3]
The Hwato brand appears in the manufacturer's published SDZ-II manual, which names Suzhou Medical Appliance Factory as the manufacturer and lists hwato-med.com contact details. The FDA filing itself does not use the Hwato name, so the brand link rests on that manual rather than on the clearance record. [5]
Context in the product-code record
Product code BWK records include other needle stimulator clearances, such as K244030 for Wuxi Jiajian Medical Instrument covering the CMNS6-1 PLUS and CMNS6-3, as listed by FDA.report. The same product-code listing shows device class U, review panel NE, implant N, life sustaining/supporting N, GMP exempt N, and third-party review N. [6]
An independent randomized controlled trial protocol published in PMC names the HWATO-SDZ-IIB, attributed to Suzhou Medical Appliance Factory, as the electroacupuncture apparatus used in that study. The citation establishes that a named model was used in a research setting; it does not establish commercial availability, clinical efficacy, or performance of the cleared models. [8]
